Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Operations (Unaudited)

v3.8.0.1
Consolidated Statements of Operations and Comprehensive Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2018
Apr. 01, 2017
Income Statement [Abstract]    
Net sales $ 78,385 $ 80,833
Cost of sales [1] 54,926 57,046
Gross profit 23,459 23,787
Operating expenses:    
Marketing 9,982 10,314
General and administrative 4,885 4,801
Fulfillment 5,848 6,082
Technology 1,088 1,273
Amortization of intangible assets 47 112
Total operating expenses 21,850 22,582
Income from operations 1,609 1,205
Other income (expense):    
Other income, net 1 16
Interest expense (433) (378)
Total other expense, net (432) (362)
Income from continuing operations before income taxes 1,177 843
Income tax provision 442 27
Income from continuing operations 735 816
Discontinued operations    
Loss from operations and disposal of discontinued AutoMD operations [2] 0 (558)
Income tax provision [2] 0 1
Loss on discontinued operations [2] 0 (559)
Net income 735 257
Other comprehensive income (loss):    
Foreign currency translation adjustments 19 (2)
Total other comprehensive income (loss) 19 (2)
Comprehensive income $ 754 $ 255
Income from continuing operations per share:    
Basic income from continuing operations per share (in usd per share) $ 0.02 $ 0.02
Diluted income from continuing operations per share (in usd per share) $ 0.02 $ 0.02
Weighted average common shares outstanding:    
Shares used in computation of basic income from continuing operations per share (in shares) 34,821 34,510
Shares used in computation of diluted income from continuing operations per share (in shares) 38,066 40,231
[1] Excludes depreciation and amortization expense which is included in marketing, general and administrative and fulfillment expense.
[2] During March 2017, AutoMD filed for dissolution and the AutoMD operating segment has been classified as discontinued operations.